Drozgyik András, Kollár Dániel, Dankházi Levente, Harmati István Á, Szalay Krisztina, Molnár Tamás F
Department of Burns and Plastic Surgery, Petz Aladár University Teaching Hospital, 9024 Győr, Hungary.
Doctoral School of Clinical Sciences, University of Pécs Medical School, 7624 Pécs, Hungary.
Biomedicines. 2024 Oct 27;12(11):2466. doi: 10.3390/biomedicines12112466.
The incidence of non-palpable breast cancer is increasing due to widespread screening and neo-adjuvant therapies. Among the available tumor localization techniques, radio-guided occult lesion localization (ROLL) has largely replaced wire-guided localization (WGL). The aim of this study was to compare the ROLL and WGL techniques in terms of the effectiveness of isotopic marking of axillary sentinel lymph nodes and to assess patient perspectives along with surgeon and radiologist preferences. A single-center, prospective, randomized study enrolled 110 patients with non-palpable breast lesions (56 ROLL, 54 WGL). Breast type, tumor volume, location, histological and radiological features, and localization/surgical duration were evaluated in the context of sentinel lymph node marking using isotope (technetium-99m-labeled human serum albumin) and blue dye. Statistical analysis was performed with significance set at < 0.05 and strong significance at < 0.01. A single-center, prospective, randomized study enrolled 110 patients with non-palpable breast lesions (56 ROLL, 54 WGL). Breast type, tumor volume, location, histological and radiological features, and localization/surgical duration were evaluated in the context of sentinel lymph node marking using isotope (technetium-99m-labeled human serum albumin) and blue dye. Statistical analysis was performed with significance set at < 0.05 and strong significance at < 0.01. While ROLL provided advantages in terms of patient comfort and logistical simplicity, WGL was superior for axillary sentinel lymph node marking, particularly in inner quadrant tumors, suggesting that WGL may be preferred in these cases.
由于广泛的筛查和新辅助治疗,不可触及性乳腺癌的发病率正在上升。在现有的肿瘤定位技术中,放射性引导隐匿性病变定位(ROLL)已在很大程度上取代了钢丝引导定位(WGL)。本研究的目的是比较ROLL和WGL技术在腋窝前哨淋巴结同位素标记有效性方面的差异,并评估患者的观点以及外科医生和放射科医生的偏好。一项单中心、前瞻性、随机研究纳入了110例不可触及性乳腺病变患者(56例采用ROLL,54例采用WGL)。在使用同位素(锝-99m标记的人血清白蛋白)和蓝色染料进行前哨淋巴结标记的背景下,对乳腺类型、肿瘤体积、位置、组织学和放射学特征以及定位/手术持续时间进行了评估。进行统计分析时,显著性设定为<0.05,强显著性设定为<0.01。一项单中心、前瞻性、随机研究纳入了110例不可触及性乳腺病变患者(56例采用ROLL,54例采用WGL)。在使用同位素(锝-99m标记的人血清白蛋白)和蓝色染料进行前哨淋巴结标记的背景下,对乳腺类型、肿瘤体积、位置、组织学和放射学特征以及定位/手术持续时间进行了评估。进行统计分析时,显著性设定为<0.05,强显著性设定为<0.01。虽然ROLL在患者舒适度和后勤简便性方面具有优势,但WGL在腋窝前哨淋巴结标记方面更具优势,尤其是在内象限肿瘤中,这表明在这些情况下可能更倾向于使用WGL。